Patrick O. Hanafin
University of North Carolina at Chapel Hill(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Cystic Fibrosis Research Advances, Inhalation and Respiratory Drug Delivery, Tuberculosis Research and Epidemiology
Most-Cited Works
- → Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing(2020)45 cited
- → Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients(2021)31 cited
- → A mechanism‐based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID‐19 treatment in humans(2020)29 cited
- → A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients(2023)21 cited
- → Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections(2021)21 cited
- → Evaluation Strategies for Triple‐Drug Combinations against Carbapenemase‐Producing Klebsiella Pneumoniae in an In Vitro Hollow‐Fiber Infection Model(2021)19 cited
- → Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis(2021)18 cited
- → A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections(2022)14 cited
- → Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and Safety(2019)13 cited
- → Proof‐of‐concept for incorporating mechanistic insights from multi‐omics analyses of polymyxin B in combination with chloramphenicol against Klebsiella pneumoniae(2023)6 cited